PARP inhibitor combo shows early promise for patients with and without BRCA mutations

How do we select patients for radium 223?

ecancermedicalscience editor's choice for February 2015

Effectiveness of adjuvant chemotherapy on patients with bladder cancer

ASCO GU 2015 news roundup

Taxane response in prostate cancer may not be influenced by androgen receptor variations

Adjuvant treatment with sorafenib or sunitinib does not improve outcomes in localised renal carcinoma

Implications of using adjuvant sorafenib and sunitinib in unfavourable renal carcinoma

Combination of dalantercept plus axitinib versus placebo plus axitinib in advanced clear cell renal cell carcinoma

Docetaxel with androgen deprivation therapy combo in hormone-naïve metastatic prostate cancer

VEGF targeted therapy and chemo an active combination in rapidly progressive renal cell carcinoma

Impact of statins on survival outcomes in metastatic renal cell carcinoma